 |
|
 |
| |
 |
|
Class Information
Number: 424/187.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Retroviridae (e.g., feline leukemia, etc.)
Description: Subject matter wherein the virus belongs to the family Retroviridae.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7348136 |
Method and device for detecting feline immunodeficiency virus |
Mar. 25, 2008 |
| 7335360 |
Method and device for detecting feline immunodeficiency virus |
Feb. 26, 2008 |
| 7306804 |
HIV-specific T-cell induction |
Dec. 11, 2007 |
| 7291338 |
Method and device for detecting feline immunodeficiency virus |
Nov. 6, 2007 |
| 7285272 |
Method and device for detecting feline immunodeficiency virus |
Oct. 23, 2007 |
| 7285278 |
Method and device for detecting feline immunodeficiency virus |
Oct. 23, 2007 |
| 7201903 |
Method and device for detecting feline immunodeficiency virus |
Apr. 10, 2007 |
| 7118888 |
Gene expression vaccine |
Oct. 10, 2006 |
| 7118874 |
Immunogenic formulation and process for preparation thereof |
Oct. 10, 2006 |
| 7094550 |
Method to determine TGF-beta |
Aug. 22, 2006 |
| 7078483 |
Retroviral vectors including modified envelope escort proteins |
Jul. 18, 2006 |
| 7033751 |
Antigenic fragment of human T-lymphotropic virus |
Apr. 25, 2006 |
| 7030234 |
Non-M, non-O HIV-1 strains, fragments and uses |
Apr. 18, 2006 |
| 7022325 |
CD8 epitope from HIV-1 protein Vpu |
Apr. 4, 2006 |
| 6936246 |
Passive immunization of ASCR for prion disorders |
Aug. 30, 2005 |
| 6806055 |
HIV envelopolype peptides |
Oct. 19, 2004 |
| 6670466 |
Human endogenous retrovirus in breast cancer |
Dec. 30, 2003 |
| 6656471 |
HIV-specific T-cell induction |
Dec. 2, 2003 |
| 6602705 |
Expression of HIV polypeptides and production of virus-like particles |
Aug. 5, 2003 |
| 6602505 |
Viral chimeras comprised of CAEV and HIV-1 genetic elements |
Aug. 5, 2003 |
| 6582703 |
Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
Jun. 24, 2003 |
| 6579526 |
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
Jun. 17, 2003 |
| 6573091 |
Chimeric viral packaging signal without gag gene sequences |
Jun. 3, 2003 |
| 6528250 |
Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments |
Mar. 4, 2003 |
| 6514692 |
Method for treatment of immunodeficiency virus infection |
Feb. 4, 2003 |
| 6495315 |
Channel forming toxins as antiviral agents |
Dec. 17, 2002 |
| 6455265 |
Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection |
Sep. 24, 2002 |
| 6447993 |
Multi-subtype FIV vaccines |
Sep. 10, 2002 |
| 6444442 |
Method of producing a recombinant non-glycosylated gp90 of equine infectious anemia virus (EIAV), and product thereof |
Sep. 3, 2002 |
| 6406841 |
Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides |
Jun. 18, 2002 |
| 6392029 |
HIV chemokines |
May. 21, 2002 |
| 6365727 |
DNA and peptides of a diabetes-specific endogenous retrovirus |
Apr. 2, 2002 |
| 6326007 |
Attenuated lentivirus vectors expressing interferon |
Dec. 4, 2001 |
| 6303120 |
Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
Oct. 16, 2001 |
| 6287565 |
Modified HGP-30 heteroconjugates, compositions and methods of use |
Sep. 11, 2001 |
| 6287572 |
Anti-HIV peptides and proteins |
Sep. 11, 2001 |
| 6261806 |
Molecular sequence of swine retrovirus and methods of use |
Jul. 17, 2001 |
| 6254872 |
Multi-subtype FIV vaccines |
Jul. 3, 2001 |
| 6184025 |
Viral isolates associated with multiple sclerosis |
Feb. 6, 2001 |
| 6146628 |
Biotherapeutic agents comprising recombinant PAP and PAP mutants |
Nov. 14, 2000 |
| 6143330 |
Compositions for inhibiting dental caries and/or middle ear infections and uses thereof |
Nov. 7, 2000 |
| 6140114 |
Defective viral vaccine particles obtained in vivo or ex vivo |
Oct. 31, 2000 |
| 6136319 |
Method of treating viral diseases in animals |
Oct. 24, 2000 |
| 6132731 |
Murine leukemia virus vectors |
Oct. 17, 2000 |
| 6132721 |
Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
Oct. 17, 2000 |
| 6129921 |
Viral ribonucleocapsid as an immunological enhancer |
Oct. 10, 2000 |
| 6113902 |
Immunogenic compositions comprising peptides from .beta.-2-microglobulin |
Sep. 5, 2000 |
| 6110465 |
Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences |
Aug. 29, 2000 |
| 6042836 |
HIV envelope polypeptides |
Mar. 28, 2000 |
| 6039957 |
Oligomeric HIV-1 envelope glycoproteins |
Mar. 21, 2000 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
